These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

227 related items for PubMed ID: 7262797

  • 1. [Hodgkin's disease--change of the therapy concept?].
    Hartwich G, Sauer R.
    Fortschr Med; 1981 Aug 06; 99(29):1113-7. PubMed ID: 7262797
    [Abstract] [Full Text] [Related]

  • 2. [Questions and aspects of radiotherapy of adult patients with localized supradiaphragmatic stage (CS I/II) Hodgkin's disease. 1. Questions and aspects on indications for primary and adjuvant radiotherapy].
    Glanzmann C, Lütolf UM.
    Strahlenther Onkol; 1993 Aug 06; 169(8):449-58. PubMed ID: 8356505
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [A retrospective analysis of the treatment results in Hodgkin's disease in a radiotherapy clinic].
    Mjaaland I, Ganser D, Freitag EM, Bohndorf W.
    Strahlenther Onkol; 1994 Sep 06; 170(9):516-23. PubMed ID: 7524173
    [Abstract] [Full Text] [Related]

  • 5. [Clinical aspects and therapy of stage III Hodgkin's disease (author's transl)].
    Weh HJ, Andrieu JM.
    MMW Munch Med Wochenschr; 1980 Jun 20; 122(25):932-4. PubMed ID: 6772941
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Hodgkin's disease. Results of diagnosis and therapy (author's transl)].
    Ranft K, Hennemann HH, Weiss A, Lengfelder W, Mantel W, Mohr-Pennert A.
    MMW Munch Med Wochenschr; 1981 Apr 24; 123(17):695-8. PubMed ID: 6785612
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Prognostic factors for children with Hodgkin's disease treated with combined-modality therapy.
    Smith RS, Chen Q, Hudson MM, Link MP, Kun L, Weinstein H, Billett A, Marcus KJ, Tarbell NJ, Donaldson SS.
    J Clin Oncol; 2003 May 15; 21(10):2026-33. PubMed ID: 12743158
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Therapeutic strategies of Hodgkin's disease].
    Lathan B, Pfreundschuh M, Diehl V.
    Internist (Berl); 1993 Feb 15; 34(2):146-54. PubMed ID: 8454428
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Mitoxantrone, vinblastine, and lomustine (CCNU) (MVC): a highly active regimen for advanced and poor-prognosis Hodgkin's disease.
    Wiernik PH, Dutcher JP, Einzig AI, Sparano J, Frank M, Friedenberg W.
    Cancer J Sci Am; 1998 Feb 15; 4(4):254-60. PubMed ID: 9689984
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. New strategies for the treatment of advanced-stage Hodgkin's lymphoma.
    Diehl V, Engert A, Re D.
    Hematol Oncol Clin North Am; 2007 Oct 15; 21(5):897-914. PubMed ID: 17908627
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.